1Beck-Sague C, Jarvis WR.The National Nosocomial Infections Surveillance System. Secular trends in the epidemiology of nosocomial infections in the United States, 1980-1990. J Infect Dis, 1993,167(2):1247-1251
2Stevens DA, Kan VL, Judson MA,et al. Practice guidelines for diseases caused by Aspergillus. Infectious Diseases Society of America. Clin Infect Dis, 2000,30(4):696-709
3Holzheimer RG, Dralle H. Management of mycoses in surgical patients-review of the literature. Eur J Med Res, 2002,7(5):200-226
4Thomas JG, Madigan M. A retrospective study to evaluate a computer based model for amplifying, 1) early antifungal intervention and 2) microbial detection of patients at risk for fungemia \.Seventh Annual Focus on Fungal Infections.San Antonio, 1997
5Alspaugh JA. Principles in the evaluation and treatment of Candiduria in adults.Clin Update Fungal Infect,2001,3(1):1-4
6Cox GM, John R. Perfect JR. Practical suggestions on the treatment of candidemia. Clinical Update in Fungal Infect, 2000,3(1):1-4
7Preston SL, Briceland LL. Fluconazole for antifungal prophylaxis in chemotherapy-induced neutropenia. Am J Health Syst Pharm, 1995,52(2):164-173
8Marcelo D, Martins MD,John, et al. Antifungal drug resistance: a focus on Candida. Clin Update Fungal Infect, 1997,3(1):1-3
9Shanmugam N, Isenmann R, Barkin JS, et al. Pancreatic fungal infection. Pancreas, 2003,27(2):133-138
10De Waele JJ, Vogelaers D, Blot S, et al. Fungal infections in patients with severe acute pancreatitis and the use of prophylactic therapy. Clin Infect Dis, 2003,37(2):208-213
